Checked.be
Active
BE 0797.066.222Private limited company
CLENIO
Avenue de Jupille 1 ·4020 Liège, Belgium· 3 yrs active
Sector: NACE 72101
(72101)
Conclusion
The computed 12-month bankruptcy probability of CLENIO is 1.0% (low). The 2024 annual accounts show equity of €603k and a net result of €382k. Its solvency ranks better than 67% of 52 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Key figures
| Equity | €603k |
| Net result | €382k |
| Better than sector | 67% |
| Active | 3 yrs |
Snowflake analysis
94
/ 100
Exceptional profile — strong across almost every axis.
Health
100
Profitability
100
Solvency
100
Growth
78
Stability
94
Bankruptcy probability (12 mo)
1.0%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−Annual accounts: healthy financial profile
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2023 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
No administrative flags
Health barometer
100
/ 100
Excellent
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative — not credit advice.
Financial overview
Annual accounts filed on 30-07-2025 with the NBB · fiscal year 2024 · volledig
Sector comparison
Fiscal year 2024 · NACE 72 · compared across all schema types (micro, abbreviated and full combined)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 72.0% | 59.4% | |
| Net result | €382k | €-440 | |
| Equity | €603k | €70k | |
| Gross operating margin | €163k | €7k | |
| Total assets | €837k | €167k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€0
—
23–24
€148k
+20.9%
+36% vs sector
€382k
+124.9%
+392% vs sector
€404k
+114.2%
+396% vs sector
€837k
+38.8%
+242% vs sector
€603k
+67.0%
+274% vs sector
€472k
+88.5%
+214% vs sector
€15k
+46.9%
23–24
€17k
-63.1%
-34% vs sector
€140k
-50.0%
+86% vs sector
€234k
-3.3%
+182% vs sector
€234k
-3.3%
+193% vs sector
3.01
+48.2%
+11% vs sector
3.01
+48.2%
+11% vs sector
72.0%
+20.3%
+9% vs sector
0.39
-42.1%
-24% vs sector
63.4%
+34.7%
+32% vs sector
45.6%
+62.0%
+44% vs sector
12.13
-97.5%
-72% vs sector
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Revenue | €0 |
| EBITDA | €148k |
| Net profit | €382k |
| Cash flow | €404k |
| Staff costs | €15k |
| Income taxes | €17k |
| Dividends | €140k |
| Total assets | €837k |
| Equity | €603k |
| Debt | €234k |
| of which ≤ 1y | €234k |
| of which > 1y | — |
| Working capital | €472k |
| Employees (FTE) | — |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 3.01 |
| Quick ratio | 3.01 |
| Working capital ratio | 56.3% |
| Solvency | 72.0% |
| Debt / equity | 0.39 |
| Long-term debt ratio | — |
| Interest coverage | 12.13 |
| Gross margin | — |
| Net margin | — |
| ROA | 45.6% |
| ROE | 63.4% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €837k |
| Fixed assets | 21/28 | €132k |
| Tangible fixed assets | 22/27 | €95k |
| Financial fixed assets | 28 | €37k |
| Current assets | 29/58 | €706k |
| Amounts receivable within one year | 40/41 | €462k |
| Investments | 50/53 | €200k |
| Cash & bank | 54/58 | €43k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €837k |
| Equity | 10/15 | €603k |
| Contributions / capital | 10/11 | €69k |
| Reserves | 13 | €241k |
| Accumulated profits (losses) | 14 | €289k |
| Amounts payable | 17/49 | €234k |
| Amounts payable within one year | 42/48 | €234k |
| Trade debts payable within one year | 44 | €6k |
| Income statement | ||
| Turnover | 70 | €0 |
| Gross operating margin | 9900 | €163k |
| Operating result | 9901 | €126k |
| Financial income | 75 | €285k |
| Financial charges | 65 | €12k |
| Result before taxes | 9903 | €399k |
| Income taxes | 67/77 | €17k |
| Net result for the period | 9904 | €382k |
| Result to be appropriated | 9905 | €389k |
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Legal Structure
| NACE primary | 72101 |
| Legal form | Private limited company(610) |
| Incorporation | 12-01-2023 |
| Status | Active |
| Postal code | 4020 |
Real-estate footprint
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62809B0332/00D004 | Wallonia | 2,483 m² | 1 · 501 m² | 12.3 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data — this is not proof of ownership.
Updates
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2025
30-07-2025
NBB filing
Annual accounts filed
2024
17-07-2024
NBB filing
Annual accounts filed
Credit advice
AI due-diligence brief
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE)
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220
Primary activity highlighted.
Names & trade names
| Legal nameFR | CLENIO |
Registered office
Avenue de Jupille 1
4020 Liège, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
Biocubik
BE 0782.955.294 · Seraing
CANCER STATE THERAPEUTICS
BE 0793.113.273 · Charleroi
pEGGY
BE 0795.890.443 · Gent
Neohla Bio
BE 0801.148.536 · Antwerpen
CureVac Belgium
BE 0781.532.859 · Ottignies-Louvain-la-Neuve